Abbonarsi

Continuous Renal Replacement Therapy for Children ≤10 kg: A Report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry - 26/02/13

Doi : 10.1016/j.jpeds.2012.08.044 
David J. Askenazi, MD, MSPH 1, , Stuart L. Goldstein, MD 2, Rajesh Koralkar, MBBS, MPH 1, James Fortenberry, MD 3, Michelle Baum, MD 4, Richard Hackbarth, MD 5, Doug Blowey, MD 6, Timothy E. Bunchman, MD 7, Patrick D. Brophy, MD 8, Jordan Symons, MD 9, Annabelle Chua, MD 10, Francisco Flores, MD 11, Michael J.G. Somers, MD 4
1 University of Alabama at Birmingham, Children’s of Alabama, Birmingham, AL 
2 Center for Acute Care Nephrology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 
3 Children’s Healthcare of Atlanta at Egleston, Emory University School of Medicine, Atlanta, GA 
4 Harvard Medical School, Children’s Hospital of Boston, Boston, MA 
5 Michigan State University, Helen DeVos Children’s Hospital, Grand Rapids, MI 
6 Children’s Mercy Hospital, Kansas City, MO 
7 Children’s Hospital of Richmond at Virginia Commonwealth University, Richmond, VA 
8 University of Iowa Children’s Hospital, Iowa City, IA 
9 University of Washington School of Medicine, Seattle Children’s Hospital, Seattle, WA 
10 Baylor College of Medicine, Houston, TX 
11 University of South Florida, Morsani College of Medicine, All Children’s Hospital, St. Petersberg, FL 

Reprint requests: David J. Askenazi, MD, MSPH, University of Alabama at Birmingham, Department of Pediatrics, Division of Nephrology, 1600 7th Ave South, ACC 516, Birmingham, AL 35233.

Abstract

Objective

To report circuit characteristics and survival analysis in children weighing ≤10 kg enrolled in the Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry.

Study design

We conducted prospective cohort analysis of the ppCRRT Registry to: (1) evaluate survival differences in children ≤10 kg compared with other children; (2) determine demographic and clinical differences between surviving and non-surviving children ≤10 kg; and (3) describe continuous renal replacement therapy (CRRT) circuit characteristics differences in children ≤5 kg versus 5-10 kg.

Results

The ppCRRT enrolled 84 children ≤10 kg between January 2001 and August 2005 from 13 US tertiary centers. Children ≤10 kg had lower survival rates than children >10 kg (36/84 [43%] versus 166/260 [64%]; P < .001). In children ≤10 kg, survivors were more likely to have fewer days in intensive care unit prior to CRRT, lower Pediatric Risk of Mortality 2 scores at intensive care unit admission and lower mean airway pressure (Paw), higher urine output, and lower percent fluid overload (FO) at CRRT initiation. Adjusted regression analysis revealed that Pediatric Risk of Mortality 2 scores, FO, and decreased urine output were associated with mortality. Compared with circuits from children 5-10 kg at CRRT initiation, circuits from children ≤5 kg more commonly used blood priming for initiation, heparin anticoagulation, and higher blood flows/effluent flows for body weight.

Conclusion

Mortality is more common in children who are ≤10 kg at the time of CRRT initiation. Like other CRRT populations, urine output and FO at CRRT initiation are independently associated with mortality. CRRT prescription differs in small children.

Il testo completo di questo articolo è disponibile in PDF.

Keyword : AKI, CRRT, %FO, FO, ICU, Paw, ppCRRT, PRISM


Mappa


 ppCRRT received unrestricted grant funding from Gambro Renal Products, Dialysis Solutions, Inc, Baxter Healthcare, and B Braun, Inc. D.A. and S.G. serve as a consultant and an expert panelist for Gambro. T.B. and F.F. serve as expert panelists for Gambro. S.G. receives grant support from Gambro and Baxter. D.A. is supported through the Norman Siegel Career Development Award from the American Society of Nephrology and received a pilot and feasibility grant from the National Institutes of Health (sponsored by the O’Brien Center for Acute Kidney Injury Research). The other authors declare no conflicts of interest.


© 2013  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 162 - N° 3

P. 587 - Marzo 2013 Ritorno al numero
Articolo precedente Articolo precedente
  • Maternal Residential Atrazine Exposure and Risk for Choanal Atresia and Stenosis in Offspring
  • A. Jack Agopian, Yi Cai, Peter H. Langlois, Mark A. Canfield, Philip J. Lupo
| Articolo seguente Articolo seguente
  • Congenital Cytomegalovirus Is the Second Most Frequent Cause of Bilateral Hearing Loss in Young French Children
  • Véronique Avettand-Fenoël, Sandrine Marlin, Christelle Vauloup-Fellous, Natalie Loundon, Martine François, Vincent Couloigner, Isabelle Rouillon, Valérie Drouin-Garraud, Laurence Laccourreye, Françoise Denoyelle, Tiffany Guilleminot, Sophie Grabar, Marianne Leruez-Ville

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.